Ilan Katz Sab Biotherapeutics, Inc. (SABS) insider trading activity

SABS Quotes by TradingView

Ilan Katz is Director of SAB Biotherapeutics, Inc.. Currently has a direct ownership of 1,500 shares of SABS, which is worth approximately $6,075. The most recent transaction as insider was on Oct 13, 2021, when has been sold 500 shares (Common Stock) at a price of $10.11 per share, resulting in proceeds of $5,055. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.5K
0% 3M change
0% 12M change
Total Value Held $6,075

Ilan Katz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 13 2021
BUY
Open market or private purchase
$5,055 $10.11 p/Share
500 Added 25.0%
1,500 Common Stock
Oct 01 2021
BUY
Open market or private purchase
$10,090 $10.09 p/Share
1,000 Added 50.0%
1,000 Common Stock
IK

Ilan Katz

Director
Miami Beach, FL

Track Institutional and Insider Activities on SABS

Follow SAB Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SABS shares.

Notify only if

Insider Trading

Get notified when an Sab Biotherapeutics, Inc. insider buys or sells SABS shares.

Notify only if

News

Receive news related to SAB Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SABS